Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cryolife (CRY)

Cryolife (CRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 810,161
  • Shares Outstanding, K 37,858
  • Annual Sales, $ 276,220 K
  • Annual Income, $ 1,720 K
  • 60-Month Beta 1.35
  • Price/Sales 2.89
  • Price/Cash Flow 26.33
  • Price/Book 2.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year 0.06
  • Growth Rate Est. (year over year) -116.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.93 +17.01%
on 07/14/20
21.93 -4.33%
on 08/10/20
+2.73 (+14.96%)
since 07/10/20
3-Month
17.36 +20.85%
on 06/18/20
25.52 -17.79%
on 06/08/20
-1.46 (-6.51%)
since 05/11/20
52-Week
12.63 +66.11%
on 03/23/20
31.77 -33.96%
on 01/29/20
-5.73 (-21.45%)
since 08/09/19

Most Recent Stories

More News
US Heart Valve Repair And Replacement Market share, Growth, Forecast By Applications, Dynamics, Development Status And Outlook 2025

The latest report pertaining to provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest...

BSX : 39.31 (+0.85%)
CRY : 20.98 (-1.96%)
LIFE : 3.82 (-4.50%)
MDT : 100.72 (+0.34%)
NVCN.TO : 3.05 (-2.56%)
STJ : 80.82 (+0.16%)
CryoLife to Participate in Upcoming Virtual Investor Conferences

, /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences....

CRY : 20.98 (-1.96%)
At 10.30% CAGR, Heart Valve Repair and Replacement Market Size Set to Register 10769.3 Million USD by 2025

The latest research report on delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrate its growth trends and...

BSX : 39.31 (+0.85%)
CRY : 20.98 (-1.96%)
LIFE : 3.82 (-4.50%)
MDT : 100.72 (+0.34%)
NVCN.TO : 3.05 (-2.56%)
STJ : 80.82 (+0.16%)
CryoLife (CRY) Reports Q2 Loss, Tops Revenue Estimates

CryoLife (CRY) delivered earnings and revenue surprises of 33.33% and 4.82%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

CRY : 20.98 (-1.96%)
CryoLife Reports Second Quarter 2020 Financial Results

, /PRNewswire/ --

CRY : 20.98 (-1.96%)
Bioprosthetic Valve Market 2020 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2026

A recent report provides crucial insights along with application based and forecast information in the Global Bioprosthetic Valve Market. The report provides a comprehensive analysis of key factors that...

BSX : 39.31 (+0.85%)
CRY : 20.98 (-1.96%)
EW : 76.66 (+1.16%)
LIVN : 47.98 (-0.15%)
MDT : 100.72 (+0.34%)
NVCN.TO : 3.05 (-2.56%)
CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results

, /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter financial results will be released on...

CRY : 20.98 (-1.96%)
Prosthetic Heart Valve Market business opportunity, and growth 2020-2025

The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.

ABT : 99.06 (-0.98%)
BSX : 39.31 (+0.85%)
CRY : 20.98 (-1.96%)
EW : 76.66 (+1.16%)
LIFE : 3.82 (-4.50%)
NVCN.TO : 3.05 (-2.56%)
STJ : 80.82 (+0.16%)
Surgical Sealants And Adhesives Global Market Report 2020-30: Covid 19 Growth and Change

Reportlinker.com announces the release of the report "Surgical Sealants And Adhesives Global Market Report 2020-30: Covid 19 Growth and Change" - https://www.reportlinker.com/p05932649/?utm_source=GNW

BAX : 82.94 (-0.19%)
CRY : 20.98 (-1.96%)
CSLLY : 100.4700 (+0.55%)
OCUL : 8.10 (-4.26%)
Global Organ and Tissue Transplantation Industry

, /PRNewswire/ -- Read the full report: Amid the COVID-19 crisis, the global market for Organ and Tissue Transplantation estimated at 137.2 Thousand Number of Transplants in the year 2020, is projected...

CRY : 20.98 (-1.96%)
EXAC : 49.25 (unch)
MFAC : 10.28 (+0.19%)
XVIPF : 16.9000 (+68.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade CRY with:

Business Summary

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical...

See More

Key Turning Points

2nd Resistance Point 22.27
1st Resistance Point 21.62
Last Price 20.98
1st Support Level 20.59
2nd Support Level 20.21

See More

52-Week High 31.77
Fibonacci 61.8% 24.46
Fibonacci 50% 22.20
Last Price 20.98
Fibonacci 38.2% 19.94
52-Week Low 12.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar